Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial

N Davarzani, LC Hewitt, MD Hale, Veerle Melotte, M Nankivell, GG Hutchins, D Cunningham, WH Allum, RE Langley, S Jolani, HI Grabsch

Research output: Contribution to journalArticleAcademic

2 Citations (Scopus)
8 Downloads (Pure)

Research programs

  • EMC OR-01

Cite this